Newer insights into the management of interstitial lung disease in systemic sclerosis
Interstitial lung disease (ILD) is a debilitating complication of systemic sclerosis (SSc) and now the leading cause of death in SSc patients, largely from progressive respiratory failure or advanced pulmonary hypertension. Despite significant advances in our understanding of the epidemiology and pa...
Saved in:
| Main Authors: | Robert L Mango, Jay H Ryu, Ashima Makol |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=194;epage=203;aulast=Mango |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates in the management of connective tissue disease-associated interstitial lung disease
by: Chengappa Kavadichanda, et al.
Published: (2021-01-01) -
Longitudinal Study of Patients with Connective Tissue Disease–Interstitial Lung Disease and Response to Mycophenolate Mofetil and Rituximab
by: Yan Li, et al.
Published: (2024-11-01) -
Connective tissue disease-associated interstitial lung disease – A multicenter observational study from India
by: Sham Santhanam, et al.
Published: (2021-01-01) -
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease
by: Emanuele Gotelli, et al.
Published: (2024-11-01) -
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents
by: Vito D’Agnano, et al.
Published: (2024-10-01)